Daniel Joyce, MD
Dr. Daniel Joyce is a surgical oncologist who specializes in cancers of the upper abdomen, including malignant peritoneal chemotherapy. He practices at the Cleveland Clinic in Cleveland, Ohio, and is skilled in the use of intraoperative radiation therapy and a complex surgical procedure that combines cytoreductive surgery to remove as much tumor material as possible with the administration of a heated, highly concentrated chemotherapy solution directly into the surgical site to kill any microscopic cancer cells left behind.[1]
Dr. Joyce also sees patients diagnosed with sarcoma, cancers of the bile duct, stomach, and pancreas, and other malignancies, working as part of a multidisciplinary team of cancer specialists to ensure that they fully understand each patient’s diagnosis and create a treatment plan that is tailored to delivering the best outcome possible.
Education and Career
Dr. Joyce earned his medical degree at the Royal College of Surgeons in Ireland and completed his internship and residency in Medicine and General Surgery at Beaumont Hospital in Dublin. He then completed a residency in General Surgery at the Cleveland Clinic and a fellowship in Complex General Surgical Oncology at Roswell Park Medicine & General Surgery.[1]
Research
Dr. Joyce has authored or co-authored over 119 peer-reviewed articles throughout his career. His research interests include a wide range of diseases and conditions and the surgical techniques that can deliver improved outcomes for patients.
Dr. Joyce’s recent publications include:[1]
Neutrophil-intrinsic TNF receptor signaling orchestrates host defense against Staphylococcus aureus. Youn C, Pontaza C, Wang Y, Dikeman DA, Joyce DP, Alphonse MP, Wu MJ, Nolan SJ, Anany MA, Ahmadi M, Young J, Tocaj A, Garza LA, Wajant H, Miller LS, Archer NK.Sci Adv. 2023 Jun 16;9(24):eadf8748. doi: 10.1126/sciadv.adf8748. Epub 2023 Jun 16.PMID: 37327341 Free PMC article.
Pan-caspase inhibition as a potential host-directed immunotherapy against MRSA and other bacterial skin infections. Alphonse MP, Rubens JH, Ortines RV, Orlando NA, Patel AM, Dikeman D, Wang Y, Vuong I, Joyce DP, Zhang J, Mumtaz M, Liu H, Liu Q, Youn C, Patrick GJ, Ravipati A, Miller RJ, Archer NK, Miller LS.Sci Transl Med. 2021 Jul 7;13(601):eabe9887. doi: 10.1126/scitranslmed.abe9887.PMID: 34233954 Free PMC article.
Ultrasound-guided foam sclerotherapy as a therapeutic modality in venous ulceration. Joyce DP, De Freitas S, Woo EY, Tang TY, Tubassam M, Walsh SR.Surgeon. 2022 Oct;20(5):e206-e213. doi: 10.1016/j.surge.2021.08.008. Epub 2021 Oct 8.PMID: 34629303 Review.
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer. Joyce DP, Kerin MJ, Dwyer RM.Int J Cancer. 2016 Oct 1;139(7):1443-8. doi: 10.1002/ijc.30179. Epub 2016 May 31.PMID: 27170104 Free article. Review.
Potentially undiagnosed cognitive impairment in patients with peripheral arterial disease: A systematic review of the literature. Joyce DP, Gracias CS, Murphy F, Tubassam M, Walsh SR, O’Hanlon S.Surgeon. 2022 Aug;20(4):e134-e143. doi: 10.1016/j.surge.2021.06.007. Epub 2021 Aug 16.PMID: 34412987 Review.
Adopting a value-based healthcare approach to deep venous obstruction and intervention. Joyce DP, Walsh SR, Tang TY.Phlebology. 2021 Feb;36(1):4-7. doi: 10.1177/0268355520948998. Epub 2020 Aug 20.PMID: 32819206 No abstract available.
